Adjuvant radiotherapy for extremity and trunk wall atypical lipomatous tumor/well-differentiated LPS (ALT/WD-LPS): a French Sarcoma Group (GSF-GETO) study-Reference-Cited by-同舟云学术

Adjuvant radiotherapy for extremity and trunk wall atypical lipomatous tumor/well-differentiated LPS (ALT/WD-LPS): a French Sarcoma Group (GSF-GETO) study

Published:2014-09 Issue:9 Volume:25 Page:1854-1860
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Cassier P.A.,Kantor G.,Bonvalot S.,Lavergne E.,Stoeckle E.,Le Péchoux C.,Meeus P.,Sunyach M.-P.,Vaz G.,Coindre J.-M.,Linassier C.,Labib A.,Delcambre C.,Bay J.-O.,Leyvraz S.,Dubergé T.,Lagrange J.-L.,Duret A.,Blay J.-Y.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference13 articles.

1. Predicting survival for well-differentiated liposarcoma: the importance of tumor location;Smith;J Surg Res,2012

2. Well-differentiated and dedifferentiated liposarcomas;Coindre;Virchows Arch,2010

3. Diagnosis and management of lipomatous tumors;Dalal;J Surg Oncol,2008

4. Liposarcoma: outcome based on the Scandinavian Sarcoma Group register;Engstrom;Cancer,2008

5. WHO Classification of Tumours of Soft Tissue and BoneFletcher CMD, Bridge JA, Hogendoorn PCW and Mertens FWHO Press, WHO, Geneva, Switzerland.

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. [Translated article] Comparative study of deep lipomas and atypical lipomatous tumours: Malignancy risk factors;Revista Española de Cirugía Ortopédica y Traumatología;2024-07

2. Estudio comparativo de lipomas profundos y tumor lipomatoso atípico. Factores pronósticos de malignidad;Revista Española de Cirugía Ortopédica y Traumatología;2024-07

3. Outcome of patients with liposarcoma: A retrospective review over 12 Years in a single center;Clinical Surgical Oncology;2024-06

4. What is the Optimal Treatment Strategy after Sarcoma R2 Surgery?;Current Treatment Options in Oncology;2024-05-29

5. UK guidelines for the management of soft tissue sarcomas;British Journal of Cancer;2024-05-11